Search results for "Tonometry"

showing 10 items of 67 documents

Chronic social defeat stress causes retinal vascular dysfunction

2021

Abstract Purpose The roles of vascular dysfunction and chronic stress have been extensively discussed in the pathophysiology of glaucoma. Our aim was to test whether chronic stress causes retinal vascular dysfunction and therewith induces retinal ganglion cells (RGCs) loss. Methods Twelve mice underwent chronic social defeat (CSD) stress, while 12 mice received control treatment only. Intraocular pressure (IOP) was measured with a rebound tonometer. Blood plasma corticosterone concentration and adrenal gland weight were used to assess stress levels. Brn-3a staining in retinas and PPD staining in optic nerve cross sections were conducted to assess the survival of RGCs and axons respectively.…

MaleRetinal Ganglion CellsIntraocular pressuremedicine.medical_specialtyCell SurvivalRetinal ArteryVideo RecordingVideo microscopyRetinal ganglionSocial DefeatMiceTonometry OcularCellular and Molecular Neurosciencechemistry.chemical_compoundRetinal DiseasesCorticosteroneInternal medicineAnimalsMedicineChronic stressIntraocular PressureTranscription Factor Brn-3ARetinaDisorder of Sex Development 46XYAdrenal Hyperplasia CongenitalEndothelin-1business.industryOptic NerveRetinalActinsSensory SystemsMice Inbred C57BLDisease Models AnimalOphthalmologyEndocrinologymedicine.anatomical_structurechemistryChronic DiseaseOptic nerveOcular Hypertensionsense organsCorticosteronebusinessStress PsychologicalExperimental Eye Research
researchProduct

Repeated intraocular pressure measurement in awake Lewis rats does not bias retinal ganglion cell survival.

2010

The TonoPen applanation tonometry is an established method for intraocular pressure (IOP) measurement. The IOP is one of the main variables affecting retinal ganglion cell (RGC) loss in experimental animal models in ophthalmology and the main risk factor for human glaucoma. In this study, we examined if IOP measurements with the TonoPen itself lead to retinal ganglion cell loss or any other possible retina damages, such as intraocular bleedings or ablation, in Lewis rats.Three groups of rats (n = 5 each) were formed. IOP monitoring, using a TonoPen XL, was performed on groups 1 and 3. Animals in groups 1 and 2 received funduscopies before and after one and two weeks of the study, in order t…

MaleRetinal Ganglion CellsIntraocular pressuremedicine.medical_specialtygenetic structuresCell SurvivalGlaucomaCell CountFundus (eye)Cellular and Molecular Neurosciencechemistry.chemical_compoundTonometry OcularOphthalmologymedicineLewis ratsAnimalsIntraocular PressureRetinabusiness.industryRetinalmedicine.diseaseeye diseasesSensory SystemsGanglionRatsOphthalmologymedicine.anatomical_structureRetinal ganglion cellchemistryRats Inbred Lewsense organsbusinessCurrent eye research
researchProduct

Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis).

2009

Purpose This prospective study examines the changes in short-term intraocular pressure (IOP) in patients with wet age-related macular degeneration (AMD) receiving intravitreal injections of 0.05 mL ranibizumab (Lucentis®) in a supine position. Methods A total of 45 eyes (45 patients, 16 M, 29 F, mean age: 78 y) received intravitreal ranibizumab injections for treatment of wet AMD (0.05 mL = 0.5 mg). The IOP was measured by Schiötz tonometry immediately preoperatively and postoperatively, and also after 3 and 10 minutes in a supine position. No history of glaucoma was present. Results The mean preoperative IOP was 22.4±5.5 mmHg in supine position. Immediately after the injection, IOP increas…

MaleVascular Endothelial Growth Factor AIntraocular pressuremedicine.medical_specialtySupine positiongenetic structuresAngiogenesis InhibitorsAntibodies Monoclonal HumanizedInjections03 medical and health sciencesTonometry Ocular0302 clinical medicineOphthalmologyRanibizumabWet age-related macular degenerationmedicineSupine PositionHumansIn patientProspective StudiesProspective cohort studyIntraocular PressureAgedAged 80 and overbusiness.industryAntibodies MonoclonalGeneral MedicineMacular degenerationMiddle Agedmedicine.diseaseeye diseasesVitreous BodyOphthalmology030221 ophthalmology & optometryWet Macular DegenerationFemalesense organsRanibizumabbusiness030217 neurology & neurosurgerymedicine.drugEuropean journal of ophthalmology
researchProduct

Refractive lens exchange with a multifocal diffractive aspheric intraocular lens

2012

PURPOSE: To evaluate the safety, efficacy and predictability after refractive lens exchange with multifocal diffractive aspheric intraocular lens implantation. METHODS: Sixty eyes of 30 patients underwent bilateral implantation with AcrySof® ReSTOR® SN6AD3 intraocular lens with +4.00 D near addition. Patients were divided into myopic and hyperopic groups. Monocular best corrected visual acuity at distance and near and monocular uncorrected visual acuity at distance and near were measured before and 6 months postoperatively. RESULTS: After surgery, uncorrected visual acuity was 0.08 ± 0.15 and 0.11 ± 0.14 logMAR for the myopic and hyperopic groups, respectively (50% and 46.67% of patients ha…

MaleVisual acuitygenetic structuresDesenho de prótesesmedicine.medical_treatmentVisual AcuityEmmetropiaIntraocular lensProsthesis designMyopia/surgerylaw.inventionNear visionLens Implantation Intraocularlcsh:OphthalmologylawTonometry ocularMyopiaProspective StudiesLenses IntraocularLens crystalline/surgeryAcuidade visualGeneral MedicineMiddle AgedLens (optics)HyperopiaTreatment OutcomeFemalemedicine.symptomLens crystallinemedicine.medical_specialtyVisual acuityMiopiaRefractive lens exchangeProsthesis DesignStatistics NonparametricOphthalmologyLens CrystallinemedicineHumansHyperopia/physiopathologyHipermetropiaCristalinoAgedPhacoemulsificationbusiness.industryReproducibility of ResultsPhacoemulsificationPresbyopiamedicine.diseaseeye diseasesOphthalmologyLens implantation intraocularlcsh:RE1-994OptometryImplantação de lentes intraocularessense organsbusinessArquivos Brasileiros de Oftalmologia
researchProduct

The Effect of Anesthetic Eye Drop Instillation on the Distribution of Corneal Thickness

2012

PURPOSE To address the effect of topical instillation of oxybuprocaine on the relative distribution of corneal thickness (CT) in young healthy subjects. METHODS Prospective study involving 30 eyes of 30 emmetropic subjects (24 ± 3 years). Corneal thickness measurements were carried out before and 3 minutes after the instillation of oxybuprocaine 4% using slit-scanning corneal topography (Orbscan topography system II). No acoustic correction factor was applied. The mean of 5 consecutive Orbscan measurements was obtained at the center and 3 mm from the visual axis in the temporal, superior, nasal, and inferior hemimeridians. RESULTS No significant mean differences were found at any corneal lo…

Malemedicine.medical_specialtyAdministration Topicalmedicine.medical_treatmentEmmetropiaTopical anestheticCorneaTonometry OcularYoung AdultOphthalmologyCorneamedicineHumansDistribution (pharmacology)Prospective StudiesAnesthetics LocalOxybuprocaineIntraocular Pressuremedicine.diagnostic_testbusiness.industryCorneal TopographyEye dropEmmetropiaCorneal topographyeye diseasesOphthalmologymedicine.anatomical_structureAnesthesiaAnestheticFemalesense organsOphthalmic SolutionsbusinessProcainemedicine.drugCornea
researchProduct

Clear Lens Extraction with Multifocal Apodized Diffractive Intraocular Lens Implantation

2007

Purpose To assess efficacy, safety, predictability, and stability after clear lens extraction (CLE) with multifocal diffractive intraocular lens (IOL) implantation. Design Prospective, nonrandomized, masked observational case series (self-controlled). Participants Two hundred twenty-four eyes of 112 consecutive patients after CLE with bilateral AcrySof ReSTOR Natural IOL implantation. Eyes were divided into myopic (mean spherical equivalent [SE], −6.01±2.71 diopters [D]) and hyperopic (mean SE, +3.86±2.52 D) groups. Methods Monocular and binocular uncorrected distance visual acuity (VA), best-corrected distance VA, uncorrected distance near VA, and best distance-corrected near VA were recor…

Malemedicine.medical_specialtyDistance visual acuitygenetic structuresmedicine.medical_treatmentAcrylic ResinsVisual AcuityEmmetropiaIntraocular lensProsthesis DesignOphthalmoscopyTonometry OcularLens Implantation IntraocularOphthalmologyLens CrystallineMyopiamedicineHumansProspective StudiesDioptreAgedLenses IntraocularClear lens extractionPhacoemulsificationmedicine.diagnostic_testbusiness.industryPhacoemulsificationPresbyopiaMiddle Agedmedicine.diseaseeye diseasesOphthalmoscopyOphthalmologyHyperopiaTreatment OutcomeOptometryFemalesense organsbusinessOphthalmology
researchProduct

Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.

2019

Purpose: To evaluate the additive intraocular pressure–lowering effect of twice-daily brinzolamide 1%/brimonidine 0.2% fixed-dose combination (BBFC) as an adjunct to a prostaglandin analog (PGA) in patients with open-angle glaucoma or ocular hypertension insufficiently controlled with PGA monotherapy. Methods: In this Phase 4, double-masked trial, patients aged ⩾18 years, with a mean intraocular pressure of ⩾19 and <32 mm Hg in at least one eye were randomized (1:1) to receive BBFC + PGA ( n = 96) or vehicle + PGA ( n = 92) for 6 weeks. The primary endpoint was the mean change in diurnal intraocular pressure from baseline (averaged over 09:00 and 11:00 h) at Week 6. Results: The mean diu…

Malemedicine.medical_specialtyOpen angle glaucomagenetic structuresFixed-dose combinationBrinzolamideThiazinesOcular hypertensionopen-angle glaucoma03 medical and health sciencesTonometry Ocular0302 clinical medicineTravoprostDouble-Blind Methodintraocular pressure reductionOphthalmologyOriginal Research ArticlesmedicineAdrenergic alpha-2 Receptor AgonistsHumansCarbonic Anhydrase InhibitorsAntihypertensive AgentsIntraocular PressureAgedAged 80 and overSulfonamidesbusiness.industryprostaglandin analogsBrimonidineBrinzolamide/brimonidine fixed-dose combinationGeneral MedicineMiddle Agedmedicine.diseaseAdjuncteye diseasesOphthalmologyDrug CombinationsProstaglandin analogBrimonidine Tartrate030221 ophthalmology & optometryLatanoprostocular hypertensionFemalesense organsbusiness030217 neurology & neurosurgeryGlaucoma Open-Anglemedicine.drugEuropean journal of ophthalmology
researchProduct

Ahmed valve, suture-less implantation: A new approach to an easier technique.

2013

Purpose Tissue adhesives have been used in ophthalmology instead of sutures to minimize the operating time. This case series investigated the effectiveness and safety of use of cyanoacrylate in Ahmed valve implantation through pars plana for refractory glaucoma. Patients and methods Seventeen eyes of 17 patients with refractory glaucoma underwent Ahmed valve scleral suture-less implantation through pars plana with a cyanoacrylate suture of the plate. Refractory glaucoma was defined as intraocular pressure (IOP) ≥ 21 mm Hg with antiglaucoma eye drops, good adherence to treatment, and no previous glaucoma surgery. IOP control and development of complications were evaluated during the follow-u…

Pars planaAdultMalemedicine.medical_specialtyIntraocular pressureTime Factorsgenetic structuresAnterior Chambermedicine.medical_treatmentGlaucomaVitrectomyPilot ProjectsProsthesis ImplantationTonometry OcularPostoperative ComplicationsOphthalmologymedicineGlaucoma surgeryHumansCyanoacrylatesProspective StudiesGlaucoma Drainage ImplantsHyphemaIntraocular PressureAgedAged 80 and overbusiness.industrySuture TechniquesRetinal detachmentGlaucomaMiddle Agedmedicine.diseaseeye diseasesOphthalmologymedicine.anatomical_structureTreatment OutcomeVitreous hemorrhageFemalesense organsbusinessJournal of glaucoma
researchProduct

Correlation of Crystallin Expression and RGC Susceptibility in Experimental Glaucoma Rats of Different Ages.

2018

Glaucoma is one of the leading causes of blindness worldwide with age being an important risk factor. However, the pathogenesis remains poorly understood. Aim of this study was to focus on age-dependent molecular changes in an experimental animal model of glaucoma.Intraocular pressure was elevated in Sprague-Dawley rats aged 3, 14, and 47 weeks for a period of 7 weeks by episcleral vein cauterization. Ganglion cell loss was monitored by an immunohistochemical staining of the Brain-specific homeobox/POU (Pit-1, Oct-2, Unc-86) domain protein 3A positive cells in retinal flat-mounts and spectral-domain optical coherence tomography measuring the retinal nerve fiber layer thickness. Molecular pr…

ProteomicsRetinal Ganglion CellsIntraocular pressureAgingGlaucomaCell CountBioinformaticsMass SpectrometryRetinaCorrelationPathogenesisRats Sprague-Dawley03 medical and health sciencesCellular and Molecular NeuroscienceTonometry Ocular0302 clinical medicineNerve FibersCrystallinMedicineAnimalsRisk factorIntraocular PressureBlindnessbusiness.industryGlaucomamedicine.diseaseCrystallinsSensory SystemsOphthalmologyDisease Models AnimalAgeing030221 ophthalmology & optometryFemalebusiness030217 neurology & neurosurgeryTomography Optical CoherenceCurrent eye research
researchProduct

Role of nitric oxide synthase isoforms for ophthalmic artery reactivity in mice.

2014

Abstract Nitric oxide synthases (NOS) are involved in regulation of ocular vascular tone and blood flow. While endothelial NOS (eNOS) has recently been shown to mediate endothelium-dependent vasodilation in mouse retinal arterioles, the contribution of individual NOS isoforms to vascular responses is unknown in the retrobulbar vasculature. Moreover, it is unknown whether the lack of a single NOS isoform affects neuron survival in the retina. Thus, the goal of the present study was to examine the hypothesis that the lack of individual nitric oxide synthase (NOS) isoforms affects the reactivity of mouse ophthalmic arteries and neuron density in the retinal ganglion cell (RGC) layer. Mice defi…

Retinal Ganglion CellsVasodilator AgentsNitric Oxide Synthase Type IIVideo microscopyVasodilationCell CountNitric Oxide Synthase Type IMuscle Smooth Vascularchemistry.chemical_compoundMiceOphthalmic ArteryPhenylephrineEnosEnzyme InhibitorsMice KnockoutbiologyAnatomySensory SystemsNitric oxide synthaseIsoenzymesVasodilationmedicine.anatomical_structureNG-Nitroarginine Methyl EsterRetinal ganglion cellKnockout mouseRetinal NeuronsNitroprussidemedicine.medical_specialtyNitric Oxide Synthase Type IIIEndothelial NOSNitric oxideCellular and Molecular NeuroscienceTonometry OcularInternal medicinemedicineAnimalsNitric Oxide DonorsIntraocular Pressurebusiness.industrybiology.organism_classificationAcetylcholineMice Inbred C57BLOphthalmologyEndocrinologychemistryVasoconstrictionbiology.proteinAdrenergic alpha-1 Receptor AgonistsEndothelium VascularbusinessExperimental eye research
researchProduct